Evidence map›Paper›PMID 42006189›Full record

ArticleGastro hep advances2026

Recompensation in Patients With Alcohol-Related Liver Disease-A Multicenter Study.

Anand V Kulkarni, Madhumita Premkumar, Karan Kumar, Akash Roy, Suprabhat Giri, Ashirvad Pasumarthy, Mithun Sharma, Shantan Venishetty, Sowmya Iyengar, Manasa Alla and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Gastro hep advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Anand V KulkarniDepartment of Hepatology, AIG Hospitals, Hyderabad, India.
Madhumita PremkumarDepartment of Hepatology, PGIMER, Chandigarh, India.
Karan KumarDepartment of Hepatology, Mahatma Gandhi Medical College, Jaipur, India.
Akash RoyDepartment of Gastrosciences, Apollo Hospitals, Kolkata, India.
Suprabhat GiriDepartment of Gastroenterology, Kalinga Institute of Medical Sciences, Bhubaneshwar, Orissa, India.
Ashirvad PasumarthyDepartment of Radiology, AIG Hospitals, Hyderabad, India.
Mithun SharmaDepartment of Hepatology, AIG Hospitals, Hyderabad, India.
Shantan VenishettyDepartment of Hepatology, AIG Hospitals, Hyderabad, India.
Sowmya IyengarDepartment of Hepatology, AIG Hospitals, Hyderabad, India.
Manasa AllaDepartment of Hepatology, AIG Hospitals, Hyderabad, India.
Rakesh KalapalaDepartment of Hepatology, AIG Hospitals, Hyderabad, India.
Padaki Nagaraj RaoDepartment of Hepatology, AIG Hospitals, Hyderabad, India.
Duvvur Nageshwar ReddyDepartment of Hepatology, AIG Hospitals, Hyderabad, India.
Ashwani K SingalDivision of Gastroenterology Hepatology and Nutrition, Department of Medicine, University of Louisville, Louisville, Kentucky.
K Rajender ReddyDepartment of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Removal of etiology of cirrhosis may lead to recompensation in decompensated cirrhosis. Few studies have reported on rates of recompensation, as per Baveno VII criteria, in viral etiology-related decompensated cirrhosis. Our aim was to assess the rate and predictors of recompensation in the spectrum of alcohol-related liver disease (ALD). Methods: Retrospective multicenter cohort study across 5 Indian centers included patients with a spectrum of ALD from January 2018 to November 2024. Clinical and biochemical data were collected and patients followed, and end points of recompensation, mortality, and transplant-free survival were evaluated. Results: Among 344 patients (age: 41.2 ± 8.4 years; Model for End-Stage Liver Disease: 23.9 ± 6.2; men: 98.3%), 242 had decompensated cirrhosis with alcohol-associated hepatitis (DC + AAH), and 102 had decompensated cirrhosis without alcohol-associated hepatitis (DC-AAH). Twenty percent (69/344) achieved recompensation as per Baveno VII criteria over 21 (range, 12-67) months. The recompensation rate was higher among those with DC-AAH (30.4%; 31/102) compared to DC + AAH (15.7%; 38/242; Conclusion: Twenty percent of patients in the spectrum of ALD demonstrated recompensation, which was associated with improved survival.

Indexed as

Alcoholic HepatitisAscitesBavenoPortal Hypertension

Identifiers

PMID42006189
PMCPMC13091198

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.